Pulmonary hypertension historical perspective: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
Jose Loyola (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pulmonary hypertension}} | {{Pulmonary hypertension}} | ||
{{CMG}}: {{AE}} {{ | {{CMG}}: {{AE}} {{Jose}} | ||
==Overview== | ==Overview== | ||
[[Pulmonary hypertension]] was first described by [[Ernst von Romberg]], a German physician, in 1891. | [[Pulmonary hypertension]] was first described by [[Ernst von Romberg]], a German physician, in 1891. |
Revision as of 15:46, 25 April 2021
Pulmonary Hypertension Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary hypertension historical perspective On the Web |
American Roentgen Ray Society Images of Pulmonary hypertension historical perspective |
Risk calculators and risk factors for Pulmonary hypertension historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]
Overview
Pulmonary hypertension was first described by Ernst von Romberg, a German physician, in 1891.
Historical Perspective
- Pulmonary hypertension was first described by Ernst von Romberg, a German physician, in 1891.
- Dresdale investigated the effects of tolzoline in a woman with pulmonary arterial hypertension causing a sudden reduction in pulmonary vascular resistance;
- In the late 1960s there was an epidemic of pulmonary arterial hypertension induced by aminorex which sparked interest on the disease;
- Pulmonary hypertension was first classified into primary and secondary in 1973 during the World Health Organization (WHO) meeting on PH in Geneva, Switzerland;
- Bosentan was approved to treat pulmonary hypertension in 2001, and sildenafil was approved in 2005.[1]
References
- ↑ Barst RJ (2008). "Pulmonary hypertension: past, present and future". Ann Thorac Med. 3 (1): 1–4. doi:10.4103/1817-1737.37832. PMC 2700428. PMID 19561874.